Tandem Diabetes Care (TNDM) EPS (Weighted Average and Diluted) (QoQ) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Tandem Diabetes Care | 1.31 Bn | 739.55 Mn | 136.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2,900.00% |
| Dec 31, 2025 | 96.77% |
| Sep 30, 2025 | 60.26% |
| Jun 30, 2025 | 60.41% |
| Mar 31, 2025 | -19,800.00% |
| Dec 31, 2024 | 102.86% |
| Sep 30, 2024 | 25.53% |
| Jun 30, 2024 | 27.69% |
| Mar 31, 2024 | -41.30% |
| Dec 31, 2023 | 9.80% |
| Sep 30, 2023 | 7.27% |
| Jun 30, 2023 | 71.35% |
| Mar 31, 2023 | -668.00% |
| Dec 31, 2022 | 67.11% |
| Sep 30, 2022 | -216.67% |
| Jun 30, 2022 | -4.35% |
| Mar 31, 2022 | -243.75% |
| Dec 31, 2021 | 77.78% |
| Sep 30, 2021 | 50.00% |
| Jun 30, 2021 | 175.00% |
| Mar 31, 2021 | -136.36% |
| Dec 31, 2020 | 246.67% |
| Sep 30, 2020 | 66.67% |
| Dec 31, 2019 | 155.56% |